IL6 and hepatocellular carcinoma: Given that IL-6 plays a key role in regulating inflammatory hepcidin expression by activating STAT3 [35, 36], we examined the roles of DP in the expression of JAK2, p-JAK2, STAT3, and p-STAT3 in HepG2 hepatoma cells treated with IL-6.